Weight-loss Drugmaker Novo Nordisk Invests $1.2 Bn In New Factory In Denmark
Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was investing 8.5 billion kroner ($1.2 billion) to build a new factory in Denmark to produce drugs against rare diseases.
Denmark’s biggest pension fund, ATP, is taking a major hit on its 2.3 billion-krone ($324 million) stake in troubled battery ...
Denmark’s preliminary tax statements or ‘forskudsopgørelse’ for 2024 have now been available to taxpayers online for around a ...
New HTA statistics produced by Denmark’s Medicinrådet for 2024 have prompted GlobalData to assess evolving HTA trends in the Nordic market.
Bavarian will transfer the technology to Serum Institute to supply the shots for Indian market. Serum Institute will also ...
Hammershus, the biggest medieval fortress in Northern Europe, holds the keys to Bornholm's vibrant history. Situated on ...
Scotland will begin their World Cup 2026 qualifying campaign away to either Denmark or Portugal on 5 September. The final ...
Friendsgivings to embracing the true meaning of "hygge," Chloé Skye Weiser has found smart ways not to let the winter blues ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback